Impact Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.64M Sell
25,081
-297
-1% -$78.4K 1.82% 10
2026
Q2
$6.45M Buy
25,378
+221
+0.9% +$51.5K 1.76% 10
2026
Q1
$6.15M Sell
25,157
-310
-1% -$72.2K 1.86% 8
2025
Q4
$5.27M Buy
25,467
+381
+2% +$75.3K 1.56% 13
2025
Q3
$4.65M Buy
25,086
+1,099
+5% +$188K 1.4% 13
2025
Q2
$3.66M Buy
23,987
+414
+2% +$63.6K 1.2% 16
2025
Q1
$3.91M Buy
23,573
+2,380
+11% +$372K 1.42% 12
2024
Q4
$3.06M Buy
+21,193
New +$3.28M 1.09% 18

Other funds holding JNJ

Impact Capital Partners's JNJ Position: Q3 2026 in Review

Impact Capital Partners reduced its Johnson & Johnson (JNJ) stake by 1.2% in Q3 2026, selling an estimated $78.4K and leaving 25,081 shares worth $6.64M. The position accounts for 1.82% of the portfolio, ranked #10.

Impact Capital Partners first reported a position in JNJ in Q4 2024 and has held it in 8 quarters since. 4,735 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Impact Capital Partners held 25,081 shares of Johnson & Johnson worth $6.64M as of Q3 2026.
  • Impact Capital Partners sold 297 Johnson & Johnson shares in Q3 2026, an estimated $78.4K.
  • Johnson & Johnson made up 1.82% of Impact Capital Partners's portfolio in Q3 2026, its #10 holding.
  • Impact Capital Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 8 quarters since.
  • 4,735 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Impact Capital Partners's 13F filing for Q3 2026, filed 22 Oct 2026.